BioHarvest Sciences Statistics

Total Valuation

BHST has a market cap or net worth of $105.73 million. The enterprise value is $113.19 million.

Market Cap	105.73M
Enterprise Value	113.19M

Important Dates

The next estimated earnings date is Saturday, February 15, 2025, after market close.

Earnings Date	Feb 15, 2025
Ex-Dividend Date	n/a

Share Statistics

BHST has 17.33 million shares outstanding. The number of shares has increased by 16.41% in one year.

Current Share Class	17.33M
Shares Outstanding	17.33M
Shares Change (YoY)	+16.41%
Shares Change (QoQ)	+6.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	25.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 2.58.

Current Ratio	0.80
Quick Ratio	0.48
Debt / Equity	2.58
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-26.95%
Return on Capital (ROIC)	-53.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.23
Inventory Turnover	3.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.82
Average Volume (20 Days)	9,816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BHST had revenue of $22.43 million and -$17.19 million in losses. Loss per share was -$1.12.

Revenue	22.43M
Gross Profit	12.11M
Operating Income	-7.85M
Pretax Income	n/a
Net Income	-17.19M
EBITDA	-7.18M
EBIT	-7.85M
Loss Per Share	-$1.12

Full Income Statement

Balance Sheet

The company has $2.77 million in cash and $10.70 million in debt, giving a net cash position of -$7.93 million or -$0.46 per share.

Cash & Cash Equivalents	2.77M
Total Debt	10.70M
Net Cash	-7.93M
Net Cash Per Share	-$0.46
Equity (Book Value)	4.14M
Book Value Per Share	0.24
Working Capital	-1.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.29 million and capital expenditures -$2.73 million, giving a free cash flow of -$10.02 million.

Operating Cash Flow	-7.29M
Capital Expenditures	-2.73M
Free Cash Flow	-10.02M
FCF Per Share	-$0.58

Full Cash Flow Statement

Margins

Gross margin is 54.00%, with operating and profit margins of -35.00% and -76.65%.

Gross Margin	54.00%
Operating Margin	-35.00%
Pretax Margin	-76.65%
Profit Margin	-76.65%
EBITDA Margin	-31.99%
EBIT Margin	-35.00%
FCF Margin	n/a

Dividends & Yields

BHST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.41%
Shareholder Yield	-16.41%
Earnings Yield	-16.26%
FCF Yield	-9.48%

Analyst Forecast

The average price target for BHST is $13.00, which is 106.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	106.68%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 3, 2024. It was a reverse split with a ratio of 0.0285714:1.

Last Split Date	Jun 3, 2024
Split Type	Reverse
Split Ratio	0.0285714:1

Scores

BHST has an Altman Z-Score of -2.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.89
Piotroski F-Score	4